Patent Issued for Engineering antimicrobial peptides (USPTO 12173343).

A patent was issued for engineering antimicrobial peptides by inventor Philippe Gabant, assigned to Syngulon SA. The patent outlines a method for generating antimicrobial peptides with predetermined levels of activity by providing a library of candidate nucleic acids encoding peptides, detecting antimicrobial activity, introducing mutations, and iterating to achieve desired levels of activity. The invention aims to tune populations of microbial organisms, such as bacteria, for industrial processes and health maintenance. The patent emphasizes the importance of antimicrobial peptides, like bacteriocins, in inhibiting the growth of microbial organisms. [Extracted from the article]